These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37700838)

  • 1. Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments.
    Sun Y; Xiong Y; Wang Q; Qiao W; Zhang H; Zhang Y
    Front Oncol; 2023; 13():1206345. PubMed ID: 37700838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation.
    Qiao W; Li J; Wang Q; Jin R; Zhang H
    J Hepatocell Carcinoma; 2024; 11():271-284. PubMed ID: 38333222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and validation of a machine learning-based nomogram to predict the prognosis of HBV associated hepatocellular carcinoma patients with high levels of hepatitis B surface antigen in primary local treatment: a multicenter study.
    Xiong Y; Qiao W; Wang Q; Li K; Jin R; Zhang Y
    Front Immunol; 2024; 15():1357496. PubMed ID: 38601167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporating Inflammatory Markers and Clinical Indicators into a Predictive Model of Single Small Hepatocellular Carcinoma Recurrence After Primary Locoregional Treatments.
    Qiao W; Xiong Y; Li K; Jin R; Zhang Y
    J Hepatocell Carcinoma; 2024; 11():1113-1125. PubMed ID: 38887683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a prognostic nomogram to predict the recurrence of AFP-negative and DCP-positive hepatocellular carcinoma after curative resection.
    Li J; Wang Q; Yan Y; Sun L; Zhang G; Li G; Jin R
    Front Oncol; 2024; 14():1414083. PubMed ID: 39175473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of Hepatocellular Carcinoma in Patients with Low Albumin-Bilirubin Grade in TACE Combined with Ablation: A Random Forest Cox Predictive Model.
    Xiong Y; Qiao W; Mei T; Li K; Jin R; Zhang Y
    J Hepatocell Carcinoma; 2024; 11():1375-1388. PubMed ID: 39005969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic model for predicting recurrence in hepatocellular carcinoma patients with high systemic immune-inflammation index based on machine learning in a multicenter study.
    Lu N; Sheng S; Xiong Y; Zhao C; Qiao W; Ding X; Chen J; Zhang Y
    Front Immunol; 2024; 15():1459740. PubMed ID: 39315112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
    Yang C; Wang H; Liu J; Yang F; Lv L; Jiang Y; Cai Q
    Front Oncol; 2023; 13():1134933. PubMed ID: 37124520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic nomogram based on the gamma-glutamyl transpeptidase-to-platelet ratio for patients with compensated cirrhotic hepatocellular carcinoma after local ablation.
    Qiao W; Li J; Wang P; Zhang Y; Jin R; Li J
    Front Oncol; 2024; 14():1406764. PubMed ID: 39055565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram Based on Platelet-Albumin-Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
    Yang C; Wu X; Liu J; Wang H; Jiang Y; Wei Z; Cai Q
    J Hepatocell Carcinoma; 2023; 10():43-55. PubMed ID: 36660412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.
    Mao S; Yu X; Shan Y; Fan R; Wu S; Lu C
    J Hepatocell Carcinoma; 2021; 8():1355-1365. PubMed ID: 34805014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel nomogram to predict the overall survival of early-stage hepatocellular carcinoma patients following ablation therapy.
    Zhang H; Sheng S; Qiao W; Han M; Jin R
    Front Oncol; 2024; 14():1340286. PubMed ID: 38384805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram built based on machine learning to predict recurrence in early-stage hepatocellular carcinoma patients treated with ablation.
    Zhang H; Sheng S; Qiao W; Sun Y; Jin R
    Front Oncol; 2024; 14():1395329. PubMed ID: 38800405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of a Nomogram to Predict the Recurrence of HCC Patients Undergoing CECT After Ablation.
    Qiao W; Fan Z; Wang Q; Jin R; Hu C
    J Hepatocell Carcinoma; 2024; 11():65-79. PubMed ID: 38235069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics.
    Zhang M; Wang Q; Zhang G; Li G; Jin R; Xing H
    Front Pharmacol; 2024; 15():1360478. PubMed ID: 38434702
    [No Abstract]   [Full Text] [Related]  

  • 16. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Low HBV-DNA Viral Load on Recurrence in Hepatocellular Carcinoma Patients Who Underwent Primary Locoregional Treatment and the Development of a Nomogram Prediction Model.
    Xiong Y; Wang Z; Liu J; Li K; Zhang Y
    Microorganisms; 2024 May; 12(5):. PubMed ID: 38792805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram Based on Systemic Immune Inflammation Index and Prognostic Nutrition Index Predicts Recurrence of Hepatocellular Carcinoma After Surgery.
    Yang J; Bao Y; Chen W; Duan Y; Sun D
    Front Oncol; 2020; 10():551668. PubMed ID: 33163397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Predictive Nomogram of Early Recurrence for Patients with AFP-Negative Hepatocellular Carcinoma Underwent Curative Resection.
    Li W; Han L; Xiao B; Li X; Ye Z
    Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.